Profession Notes

NIH Lauches Global AIDS Initiative On World Aids Day last December 1, President Bill Clinton announced a new global initiative whereby the National Institutes of Health will spend more than $100 million in FY 2001 research funding with international partners. Jack Whitescarver, acting directing of the NIH Office of AIDS Research formally announced the "Global AIDS Research Initiative and Strategic Plan" at a lecture later that day. Anthony S. Fauci, director of the National Institute of Allerg

Written byKate Devine
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

On World Aids Day last December 1, President Bill Clinton announced a new global initiative whereby the National Institutes of Health will spend more than $100 million in FY 2001 research funding with international partners. Jack Whitescarver, acting directing of the NIH Office of AIDS Research formally announced the "Global AIDS Research Initiative and Strategic Plan" at a lecture later that day. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, followed with a discussion of developments in epidemiology, pathogenesis, treatment, and prevention of the disease. Among the sobering statistics Fauci delivered: 22 million have died worldwide of AIDS and 36 million currently live with HIV/AIDS. At a national level, in South Africa, a predicted 50 percent of the population under 15 will die from the disease and many developing nations in Asia, Latin America, the Caribbean, and the former Soviet Union are facing critical situations ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies